Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, is proud to announce its ...

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...

Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) shares were up 6.6% during trading on Tuesday after Canaccord Genuity Group raised their price target on the stock from $28.00 to $38.00.

Hims & Hers Health (NYSE:HIMS – Get Free Report) had its price objective increased by equities research analysts at Canaccord Genuity Group from $28.00 to $38.00 in a report released on ...

Dr. Lokesh, Associate Professor in the Department of General Medicine in the Hassan Institute of Medical Sciences, was ...

The American Diabetes Association is advising doctors and patients not to use compounded GLP-1s due to uncertainty about their content, safety, ...

Eleven cases of hypertrichosis — commonly known as “werewolf syndrome” — has developed in babies throughout Spain.

European authorities are asking for the label on a popular drug to be amended after a series of reports linked the medication to 'werewolf syndrome' in children.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Some of the most popular market trends over the past few years have been artificial intelligence (AI) and cryptocurrency.

Shares of healthcare giant CVS Health Corp (NYSE:CVS) are 1.5% higher before the bell, after a bull note at Deutsche Bank.